Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-580875
Filing Date
2016-05-06
Accepted
2016-05-06 07:11:11
Documents
6
Period of Report
2016-06-23
Effectiveness Date
2016-05-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d167367ddef14a.htm DEF 14A 281040
2 GRAPHIC g167367g09c47.jpg GRAPHIC 31561
3 GRAPHIC g167367g15x80.jpg GRAPHIC 34904
4 GRAPHIC g167367g64d71.jpg GRAPHIC 35457
5 GRAPHIC g167367pcpg001.jpg GRAPHIC 1996
6 GRAPHIC g167367pcpg002.jpg GRAPHIC 2003
  Complete submission text file 0001193125-16-580875.txt   417311
Mailing Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36829 | Film No.: 161625873
SIC: 2834 Pharmaceutical Preparations